NCT04531358View on ClinicalTrials.gov

Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 4, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Allergic RhinitisAllergic Rhinoconjunctivitis
Interventions
DEVICE

nasal spray

application of nasal spray

OTHER

no treatment

no treatment

Trial Locations (1)

1140

Ordination Dr. Petra Zieglmayer Vienna Challenge Chamber, Vienna

Sponsors
All Listed Sponsors
lead

Marinomed Biotech AG

INDUSTRY

NCT04531358 - Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis | Biotech Hunter | Biotech Hunter